Skip to main content
. 2022 Aug 24;10(9):1375. doi: 10.3390/vaccines10091375

Table 3.

Annual hospitalisation for pneumococcal-specific pneumonia and IPD between 2012–2018, by age cohort.

Age, Years Year Cases Per 100,000 Person-Years(95% CI)
Pneumococcal-Specific Pneumonia IPD
0–14 2012 35 (26–44) 1.70 (−0.22–3.62)
2013 30 (22–38) 2.27 (0.05–4.50)
2014 29 (21–37) 4.01 (1.04–6.98)
2015 26 (18–33) 2.32 (0.05–4.60)
2016 9 (4–13) 3.53 (0.71–6.36)
2017 24 (17–32) 7.17 (3.11–11.22)
2018 13 (8–19) 4.85 (1.49–8.20)
0–1 2012 79 (30–128) 0.00 (0.00–0.00)
2013 39 (5–74) 0.00 (0.00–0.00)
2014 74 (26–123) 0.00 (0.00–0.00)
2015 94 (39–150) 8.55 (−8.21–25.31)
2016 36 (1–71) 8.97 (−8.61–26.55)
2017 146 (75–218) 18.26 (−7.05–43.57)
2018 47 (6–88) 9.41 (−9.03–27.86)
2–4 2012 69 (43–96) 5.33 (−2.06–12.71)
2013 60 (35–86) 8.24 (−1.08–17.56)
2014 74 (45–102) 0.00 (0.00–0.00)
2015 52 (28–77) 5.83 (−2.25–13.90)
2016 15 (2–28) 5.96 (−2.30–14.23)
2017 34 (14–54) 18.61 (3.72–33.51)
2018 22 (6–39) 9.57 (−1.26–20.41)
5–14 2012 21 (13–28) 0.79 (−0.76–2.34)
2013 20 (13–28) 0.79 (−0.76–2.33)
2014 12 (6–18) 5.51 (1.43–9.59)
2015 12 (6–18) 0.79 (−0.76–2.35)
2016 5 (1–9) 2.40 (−0.32–5.11)
2017 11 (5–17) 3.22 (0.06–6.38)
2018 8 (3–13) 3.25 (0.07–6.43)

CI: confidence interval; IPD: invasive pneumococcal disease.